Search - tctmd.com

Displaying 1 - 12 of 12

Sort: Relevancy | Date

Presentation THT 2026

Overview of Ongoing Studies with Gene Therapy for Cardiovascular Diseases

Presenter: Joe Rossano

March 03, 2026

Presentation THT 2026

Identifying and Preventing Toxicity

Presenter: Eric D. Adler

March 03, 2026

Presentation THT 2026

Designing Studies for Gene Therapy for Rare Diseases

Presenter: Barry Greenberg

March 03, 2026

Presentation THT 2026

Defining the Targets for Gene Therapy and Optimizing Vectors for Delivery

Presenter: Roger J. Hajjar

March 03, 2026

Presentation THT 2026

LVADs to Jumpstart the Process of Myocardial Regeneration

Presenter: Stavros G. Drakos

March 02, 2026

Presentation THT 2026

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Presenter: Sunjay Kaushal

March 02, 2026

Presentation THT 2026

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Presenter: Eugene Jiaxian Wang

March 02, 2026

Presentation THT 2026

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Presenter: Kathy Ivey

March 02, 2026

Presentation THT 2026

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Presenter: James F. Martin

March 02, 2026

Presentation THT 2026

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Presenter: Eric D. Adler

March 02, 2026

Presentation THT 2026

Overview of Gene Therapies for Specific Cardiomyopathies

Presenter: Barry Greenberg

March 02, 2026

Partner Content

Clinical Evidence Shaping Personalized DAPT Strategies

January 23, 2026

Advertisement

Overview of Ongoing Studies with Gene Therapy for Cardiovascular Diseases

Identifying and Preventing Toxicity

Designing Studies for Gene Therapy for Rare Diseases

Defining the Targets for Gene Therapy and Optimizing Vectors for Delivery

LVADs to Jumpstart the Process of Myocardial Regeneration

The CHILD Trial: Phase I Randomized Study of Cardiac Stem Cells in Patients with Hypoplastic Left Heart Syndrome

Implantation of iPS Cells Differentiated into Cardiomyocytes to Repair the Damaged Myocardium

Cardiac Reprogramming Cocktail Delivered in a Single Adeno-Associated Virus to Improve Function in a Porcine Model of Ischemic Heart Failure

Inducing Cardiomyocyte Proliferation Using Native Cell Cycle Pathways to Create More Cardiomyocytes

Treating Danon Disease with Gene Therapy: Lessons Learned and Prospects for the Future

Overview of Gene Therapies for Specific Cardiomyopathies

Clinical Evidence Shaping Personalized DAPT Strategies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content